查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876774

2032年居家機器人輔助復健市場預測：按類型、治療類型、最終用戶和地區分類的全球分析

Home-Based Robot Assisted Rehabilitation Market Forecasts to 2032 - Global Analysis By Type (Robot Type, Sensor Type, and Deployment Mode), Therapy Type, End User, and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，預計到 2025 年，全球家庭機器人輔助復健市場規模將達到 4.281 億美元，到 2032 年將達到 11.524 億美元，預測期內複合年成長率為 15.2%。

居家機器人輔助復健利用家庭環境中的機器人設備，輔助中風、創傷和神經系統疾病患者的物理治療。這些系統提供指導性鍛鍊、即時回饋和自適應阻力，從而實現個人化復健方案。它們與遠端醫療平台整合，便於臨床醫生進行遠端監測，並提高患者的依從性。這項技術減少了就診次數，降低了成本，並提高了老年人的康復便利性。目前，居家機器人輔助復健正擴大應用於術後護理和慢性病管理，填補了傳統復健服務的空白。

約翰霍普金斯大學的一項研究發現，中風後使用配備感測器的機器人輔助進行上肢復健治療的患者，與接受標準家庭運動計畫的患者相比，在任務準確性和一致性方面提高了 30%。

老化和中風後人群

全球人口老化和中風相關殘疾發生率的上升，推動了居家機器人輔助復健的需求。這些系統提供個人化治療，改善行動能力，並減少對醫院就診的依賴。隨著人口老化和慢性病的盛行率增加，機器人復健為長期照護提供了一種擴充性且經濟高效的解決方案。各國政府和醫療機構正在投資輔助技術，以支持獨立生活並減輕醫院的負擔。這種人口結構變化是市場擴張的主要驅動力。

較高的初始實施和維修成本

儘管機器人復健系統具有許多臨床益處，但其高昂的前期成本限制了其廣泛應用。這些成本包括硬體、軟體整合、培訓和持續維護。這些費用通常不在保險範圍內，使得許多家庭難以負擔。此外，技術複雜性和定期維護的需求也增加了營運負擔。在建立經濟高效的模式和報銷機制之前，市場滲透率將持續受限，尤其是在低收入和農村地區。

與遠端醫療復健計劃的整合

將機器人復健系統與遠端醫療平台結合，蘊藏著巨大的發展機會。遠端監測、虛擬治療和人工智慧驅動的進度追蹤，顯著提升了醫療服務的可及性和連續性。患者足不出戶即可獲得臨床醫師的指導和回饋。這種混合模式有助於術後復健、慢性病管理和中風復健。隨著遠端醫療的普及，機器人技術與數位醫療基礎設施的整合將催生新的服務模式，並將服務範圍擴展到醫療資源匱乏的地區。

機器人療法的監管障礙

機器人復健系統面臨複雜的監管路徑，尤其是在家庭使用方面。核准流程因地區而異，通常需要大量的臨床檢驗。安全性、有效性和資料隱私標準必須滿足，這會延緩市場准入並增加合規成本。此外，遠距復健和機器人介入缺乏統一的指導方針，也為製造商帶來了不確定性。這些監管挑戰會減緩創新，限制跨國擴充性，並對快速商業化構成威脅。

新冠疫情的影響：

新冠疫情加速了對遠距復健解決方案的需求，包括居家機器人系統。封鎖措施和醫療資源緊張凸顯了分散式醫療服務的必要性。中風或手術後的患者可以在家中接受機器人治療，從而降低感染風險。疫情危機刺激了對遠端醫療和數位化治療的投資，為機器人復健創造了有利環境。疫情結束後，結合線上線下治療的混合式醫療模式日益普及，再次印證了居家機器人解決方案的長期重要性。

預計在預測期內，機器人類型細分市場將佔據最大佔有率。

由於其多功能性和治療精準性，機器人類復健系統預計將主導市場。這些系統包括外骨骼、末端執行器機器人和穿戴式設備，專為上肢和下肢復健而設計。它們能夠提供重複的、特定任務的運動，從而促進運動功能恢復並提高患者參與治療的動機。隨著科技的進步，機器人正變得更加小巧、易於使用且價格更實惠。經臨床檢驗的有效性和不斷提高的患者接受度進一步鞏固了該領域在家庭復健領域的主導地位。

預計在預測期內，運動復健領域將實現最高的複合年成長率。

受中風後和整形外科復健需求不斷成長的推動，運動功能恢復領域預計將實現最高的複合年成長率。機器人系統提供針對性的訓練，可增強肌肉力量、協調性和神經可塑性。人工智慧演算法可根據患者的復健進展制定個人化治療方案，進而改善治療效果。人們日益認知到早期療育的重要性，這推動了運動功能恢復工具在急性和慢性疾病中的應用。該領域的擴充性和可衡量的影響是機器人復健的關鍵促進因素。

佔比最大的地區：

由於人口老化、中風發病率上升以及醫療基礎設施不斷完善，亞太地區預計將在預測期內佔據最大的市場佔有率。中國、日本和韓國等國家正在投資輔助科技和居家照護模式。政府為促進數位醫療和復健服務而採取的措施進一步推動了這些技術的普及。當地製造商和Start-Ups公司正在開發符合當地需求的、經濟高效的機器人解決方案。該地區的人口結構和政策環境使其成為機器人復健領域的領導者。

預計複合年成長率最高的地區：

在預測期內，北美預計將實現最高的複合年成長率，這主要得益於其先進的醫療保健生態系統、強大的研發能力以及對機器人療法的早期應用。在美國和加拿大，家庭復健正在整合到遠端醫療平台中，並得到了有利的報銷政策的支持。主要企業和學術機構正在推動人工智慧機器人技術的創新。人們對中風後復健和慢性病管理的日益重視正在推動市場需求。監管支持和創業投資投資進一步促進了全部區域的市場成長。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球家用機器人輔助復健市場（按類型分類）

  • 介紹
  • 機器人類型
    • 外骨骼機器人
    • 末端執行器機器人
    • 穿戴式機器人
    • 治療陪伴機器人
  • 感測器類型
    • 動作感測器
    • 壓力感測器
    • 肌電感測器
    • 溫度和生物回饋療法感測器
  • 部署模式
    • 獨立式住宅單元
    • 雲端連線系統
    • 行動應用整合裝置

6. 全球家庭機器人輔助復健市場（依治療類型分類）

  • 介紹
  • 運動功能恢復
  • 認知復健
  • 中風後治療
  • 整形外科復健

7. 全球家用機器人輔助復健市場（依最終用戶分類）

  • 介紹
  • 老年患者
  • 術後患者
  • 神經系統疾病患者

8. 全球家用機器人輔助復健市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章：重大發展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第10章：企業概況

  • Hocoma AG
  • ReWalk Robotics
  • Ekso Bionics
  • Myomo Inc.
  • Motus Nova
  • Tyromotion
  • Ottobock
  • Cyberdyne Inc.
  • Bionik Laboratories
  • Parker Hannifin
  • AlterG Inc.
  • Fourier Intelligence
  • Kinova
  • Rehab-Robotics Co.
  • MediTouch Ltd.
  • Hyundai Motor Company
  • SuitX
  • Palladyne AI
Product Code: SMRC32361

According to Stratistics MRC, the Global Home-Based Robot Assisted Rehabilitation Market is accounted for $428.1 million in 2025 and is expected to reach $1152.4 million by 2032 growing at a CAGR of 15.2% during the forecast period. Home-Based Robot Assisted Rehabilitation involves using robotic devices in domestic settings to support physical therapy for stroke, injury, or neurological conditions. These systems offer guided exercises, real-time feedback, and adaptive resistance, enabling personalized recovery programs. Integrated with telehealth platforms, they allow remote monitoring by clinicians and improve patient adherence. The technology reduces hospital visits, lowers costs, and enhances accessibility for aging populations. It's increasingly adopted in post-operative care and chronic condition management, bridging gaps in traditional rehabilitation services.

According to a Johns Hopkins University study, patients using sensor-equipped robotic guides for post-stroke upper-limb therapy showed a 30% greater improvement in task accuracy and consistency compared to those following standard home exercise programs.

Market Dynamics:

Driver:

Growing elderly and post-stroke population

The rising global elderly population and increasing incidence of stroke-related disabilities are driving demand for home-based robot-assisted rehabilitation. These systems offer personalized therapy, improve mobility, and reduce dependence on clinical visits. With aging demographics and chronic conditions on the rise, robotic rehabilitation provides scalable, cost-effective solutions for long-term care. Governments and healthcare providers are investing in assistive technologies to support independent living and reduce hospital burden. This demographic shift is a major catalyst for market expansion.

Restraint:

High initial setup and maintenance costs

Despite clinical benefits, the high upfront cost of robotic rehabilitation systems limits adoption. Expenses include hardware, software integration, training, and ongoing maintenance. These costs are often not covered by insurance, making them inaccessible for many households. Additionally, technical complexity and the need for regular servicing add to operational burdens. Until cost-effective models and reimbursement frameworks are established, market penetration will remain constrained, especially in low-income and rural settings.

Opportunity:

Integration with telehealth rehabilitation programs

The integration of robotic rehabilitation systems with telehealth platforms presents a major growth opportunity. Remote monitoring, virtual therapy sessions, and AI-driven progress tracking enhance accessibility and continuity of care. Patients can receive guided exercises and feedback from clinicians without leaving home. This hybrid model supports post-operative recovery, chronic condition management, and stroke rehabilitation. As telehealth adoption accelerates, combining robotics with digital health infrastructure will unlock new service models and expand reach across underserved populations.

Threat:

Regulatory hurdles for robotic therapies

Robotic rehabilitation systems face complex regulatory pathways, especially for home use. Approval processes vary across regions and often require extensive clinical validation. Safety, efficacy, and data privacy standards must be met, delaying market entry and increasing compliance costs. Additionally, lack of harmonized guidelines for tele-rehabilitation and robotic interventions creates uncertainty for manufacturers. These regulatory challenges can slow innovation and limit cross-border scalability, posing a threat to rapid commercialization.

Covid-19 Impact:

The COVID-19 pandemic accelerated demand for remote rehabilitation solutions, including home-based robotic systems. Lockdowns and strained healthcare facilities highlighted the need for decentralized care. Patients recovering from stroke or surgery benefited from robotic therapy at home, reducing exposure risks. The crisis also spurred investment in telehealth and digital therapeutics, creating a favorable environment for robotic rehabilitation. Post-pandemic, hybrid care models combining in-person and remote therapy are gaining traction, reinforcing the long-term relevance of home-based robotic solutions.

The robot type segment is expected to be the largest during the forecast period

The robot type segment is expected to dominate the market due to its versatility and therapeutic precision. These systems include exoskeletons, end-effector robots, and wearable devices designed for upper and lower limb rehabilitation. Their ability to deliver repetitive, task-specific movements enhances motor recovery and patient engagement. As technology advances, robots are becoming more compact, user-friendly, and affordable. Clinical validation and growing patient acceptance further support segment leadership in home-based rehabilitation.

The motor function recovery segment is expected to have the highest CAGR during the forecast period

Motor function recovery is projected to register the highest CAGR, driven by increasing demand for post-stroke and orthopedic rehabilitation. Robotic systems offer targeted exercises that improve muscle strength, coordination, and neuroplasticity. AI algorithms personalize therapy based on patient progress, enhancing outcomes. As awareness of early intervention grows, motor recovery tools are being adopted for both acute and chronic conditions. The segment's scalability and measurable impact make it a key growth driver in robotic rehabilitation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, supported by its aging population, rising stroke incidence, and expanding healthcare infrastructure. Countries like China, Japan, and South Korea are investing in assistive technologies and home-based care models. Government initiatives promoting digital health and rehabilitation access further boost adoption. Local manufacturers and startups are developing cost-effective robotic solutions tailored to regional needs. The region's demographic and policy landscape positions it as a leader in robotic rehabilitation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR due to its advanced healthcare ecosystem, strong R&D capabilities, and early adoption of robotic therapies. The U.S. and Canada are integrating home-based rehabilitation into telehealth platforms, supported by favorable reimbursement policies. Leading companies and academic institutions are driving innovation in AI-enabled robotics. Growing awareness of post-stroke recovery and chronic care management fuels demand. Regulatory support and venture capital investment further accelerate market growth across the region.

Key players in the market

Some of the key players in Home-Based Robot Assisted Rehabilitation Market include Hocoma AG, ReWalk Robotics, Ekso Bionics, Myomo Inc., Motus Nova, Tyromotion, Ottobock, Cyberdyne Inc., Bionik Laboratories, Parker Hannifin, AlterG Inc., Fourier Intelligence, Kinova, Rehab-Robotics Co., MediTouch Ltd., Hyundai Motor Company, SuitX and Palladyne AI.

Key Developments:

In October 2025, Hocoma AG partnered with Palladyne AI to integrate adaptive AI into its Valedo home system. The upgrade personalizes spine therapy in real-time based on patient performance and progress metrics.

In September 2025, Ekso Bionics received FDA clearance for its new EksoIndy for Home, a lightweight, user-operated exoskeleton designed for unsupervised daily use by individuals with lower-limb paralysis or weakness.

In August 2025, Myomo Inc. launched a telehealth subscription service for its MyoPro orthosis. It provides remote therapy sessions and continuous data tracking for patients with arm paralysis due to stroke or SCI.

Types Covered:

  • Robot Type
  • Sensor Type
  • Deployment Mode

Therapy Types Covered:

  • Motor Function Recovery
  • Cognitive Rehabilitation
  • Post-Stroke Therapy
  • Orthopaedic Recovery

End Users Covered:

  • Elderly Patients
  • Post-Surgical Patients
  • Neurological Disorder Patients

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Home-Based Robot Assisted Rehabilitation Market, By Type

  • 5.1 Introduction
  • 5.2 Robot Type
    • 5.2.1 Exoskeleton Robots
    • 5.2.2 End-Effector Robots
    • 5.2.3 Wearable Robotics
    • 5.2.4 Therapy Companion Robots
  • 5.3 Sensor Type
    • 5.3.1 Motion Sensors
    • 5.3.2 Pressure Sensors
    • 5.3.3 EMG Sensors
    • 5.3.4 Temperature & Biofeedback Sensors
  • 5.4 Deployment Mode
    • 5.4.1 Standalone Home Units
    • 5.4.2 Cloud-Connected Systems
    • 5.4.3 Mobile App-Integrated Devices

6 Global Home-Based Robot Assisted Rehabilitation Market, By Therapy Type

  • 6.1 Introduction
  • 6.2 Motor Function Recovery
  • 6.3 Cognitive Rehabilitation
  • 6.4 Post-Stroke Therapy
  • 6.5 Orthopaedic Recovery

7 Global Home-Based Robot Assisted Rehabilitation Market, By End User

  • 7.1 Introduction
  • 7.2 Elderly Patients
  • 7.3 Post-Surgical Patients
  • 7.4 Neurological Disorder Patients

8 Global Home-Based Robot Assisted Rehabilitation Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Hocoma AG
  • 10.2 ReWalk Robotics
  • 10.3 Ekso Bionics
  • 10.4 Myomo Inc.
  • 10.5 Motus Nova
  • 10.6 Tyromotion
  • 10.7 Ottobock
  • 10.8 Cyberdyne Inc.
  • 10.9 Bionik Laboratories
  • 10.10 Parker Hannifin
  • 10.11 AlterG Inc.
  • 10.12 Fourier Intelligence
  • 10.13 Kinova
  • 10.14 Rehab-Robotics Co.
  • 10.15 MediTouch Ltd.
  • 10.16 Hyundai Motor Company
  • 10.17 SuitX
  • 10.18 Palladyne AI

List of Tables

  • Table 1 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Robot Type (2024-2032) ($MN)
  • Table 4 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Exoskeleton Robots (2024-2032) ($MN)
  • Table 5 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By End-Effector Robots (2024-2032) ($MN)
  • Table 6 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Wearable Robotics (2024-2032) ($MN)
  • Table 7 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Therapy Companion Robots (2024-2032) ($MN)
  • Table 8 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Sensor Type (2024-2032) ($MN)
  • Table 9 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Motion Sensors (2024-2032) ($MN)
  • Table 10 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Pressure Sensors (2024-2032) ($MN)
  • Table 11 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By EMG Sensors (2024-2032) ($MN)
  • Table 12 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Temperature & Biofeedback Sensors (2024-2032) ($MN)
  • Table 13 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 14 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Standalone Home Units (2024-2032) ($MN)
  • Table 15 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Cloud-Connected Systems (2024-2032) ($MN)
  • Table 16 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Mobile App-Integrated Devices (2024-2032) ($MN)
  • Table 17 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 18 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Motor Function Recovery (2024-2032) ($MN)
  • Table 19 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Cognitive Rehabilitation (2024-2032) ($MN)
  • Table 20 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Post-Stroke Therapy (2024-2032) ($MN)
  • Table 21 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Orthopaedic Recovery (2024-2032) ($MN)
  • Table 22 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Elderly Patients (2024-2032) ($MN)
  • Table 24 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Post-Surgical Patients (2024-2032) ($MN)
  • Table 25 Global Home-Based Robot Assisted Rehabilitation Market Outlook, By Neurological Disorder Patients (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.